These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5038777)

  • 1. [Betaine aspartate in the therapy of liver diseases].
    Cairella M; Volpari B
    Clin Ter; 1972 Mar; 60(6):513-34. PubMed ID: 5038777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic activity of betaine aspartate].
    Nicrosini F
    Clin Ter; 1972 May; 61(3):227-36. PubMed ID: 5050945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Betaine aspartate in the hepato-digestive domain].
    Cachin M; Pergola F
    Sem Ther; 1966 Oct; 42(8):423-4. PubMed ID: 5994378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with betain citrate (author's transl)].
    Babucke G; Sarre B
    Med Klin; 1973 Aug; 68(34):1109-13. PubMed ID: 4364431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intravenous administration of ornithine aspartate to patients with hepatic diseases].
    Schäfer W
    Munch Med Wochenschr; 1968 Oct; 110(43):2521-5. PubMed ID: 5755238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipotropic effect of betaine aspartate on experimental hepatic steatosis. Study using triolein-C14].
    Perrault M; Dormard Y
    Therapie; 1966; 21(3):719-31. PubMed ID: 5942137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our clinical experience with ornithine aspartate].
    Szirmai E
    Minerva Med; 1971 Jun; 62(47):2376-82. PubMed ID: 5087700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
    Hunold W
    Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of liver diseases, especially of fatty liver with betaine citrate].
    Semmler F
    Ther Ggw; 1977 Nov; 116(11):2113-24. PubMed ID: 337559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Personal experiences in the treatment of internal diseases with ornithine aspartate].
    Perinović M; Robović Z; Grujić M; Ljubojević S
    Med Arh; 1969; 23(3):29-32. PubMed ID: 5200044
    [No Abstract]   [Full Text] [Related]  

  • 15. [New therapeutic aspects in substitutive treatment with homologous and heterologous enzymes of gastro-entero-biliary hyposthenic diseases].
    Palmari V; Pietranera P
    Clin Ter; 1970 May; 53(4):299-313. PubMed ID: 4918645
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new biochemical aspect of liver therapy].
    Gäbler H
    Ther Ggw; 1971 Apr; 110(4):505-14. PubMed ID: 5574294
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protection of the liver and liver therapy with Hepamerz].
    Heynen U
    Z Allgemeinmed; 1970 Jan; 46(2):87-8. PubMed ID: 5439291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic experience with the lipotropic hepatic drug Flacar in the internal medicine practice].
    Kandziora J
    ZFA (Stuttgart); 1976 Oct; 52(30):1561-3. PubMed ID: 997758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.